HOUSTON, Oct. 27, 2022 /PRNewswire/ -- Delphi Diagnostics, Inc and Quantum Leap Healthcare Collaborative™ (QLHC) announce the inclusion of Delphi's SET2,3™ test for use in the I-SPY 2 TRIAL for ...
HOUSTON, March 5, 2025 /PRNewswire/ -- Delphi Diagnostics, Inc. announces two important pieces of evidence to support the Endocrine Activity Index as a predictor of benefit from Dose-Intense ...
A consortium of global experts release proposed diagnostic criteria for vascular cognitive impairment and dementia, along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback